Earnings Feed
Start Free
Home/Filings/4/0001104659-17-012169
4//SEC Filing

SUPERNUS PHARMACEUTICALS INC 4

Accession 0001104659-17-012169

$SUPNCIK 0001356576operating
View on SEC.govCompany Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 9:55 PM ET

Size

5.5 KB

Accession

0001104659-17-012169

Insider Transaction Report

Form 4
Period: 2017-02-24
SUPERNUS PHARMACEUTICALS INCSUPN
Nuerge William A.
Director
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2017-02-24+7,905→ 7,905 total
    Exercise: $25.30From: 2018-02-24Exp: 2027-02-24→ Common Stock (7,905 underlying)
Holdings

  • Common Stock

    23,750

Documents

1 file

Issuer

SUPERNUS PHARMACEUTICALS INC

CIK 0001356576

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001356576

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 9:55 PM ET
Size
5.5 KB
View on SEC.gov